{
    "ticker": "ERAS",
    "name": "Erasca, Inc.",
    "description": "Erasca, Inc. is a biotechnology company focused on developing transformative medicines for patients with cancer. Founded in 2018, Erasca is dedicated to delivering novel therapies that target the underlying mechanisms of cancer, specifically through precision medicine. The company's innovative approach is rooted in a deep understanding of tumor biology and the genetic drivers of cancer. Erasca's pipeline includes several promising candidates aimed at treating a variety of solid tumors with high unmet medical needs. The company utilizes cutting-edge technologies to enhance drug discovery and development, ensuring that therapies are tailored to the individual characteristics of each patient's cancer. With a commitment to advancing cancer treatment, Erasca collaborates with leading research institutions and invests in research to explore new therapeutic avenues. The company's mission is to change the way cancer is treated by providing hope and improved outcomes for patients through science-driven innovation.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2018",
    "website": "https://www.erasca.com",
    "ceo": "Jack D. W. W. Lee",
    "social_media": {
        "twitter": "https://twitter.com/ErascaInc",
        "linkedin": "https://www.linkedin.com/company/erasca/"
    },
    "investor_relations": "https://investors.erasca.com",
    "key_executives": [
        {
            "name": "Jack D. W. W. Lee",
            "position": "CEO"
        },
        {
            "name": "Daniel S. O'Connor",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Oncology Treatments",
            "products": [
                "ERAS-007",
                "ERAS-601"
            ]
        }
    ],
    "seo": {
        "meta_title": "Erasca, Inc. | Transformative Cancer Therapies",
        "meta_description": "Erasca, Inc. is a biotechnology company focused on developing innovative cancer treatments through precision medicine. Learn about our mission and pipeline.",
        "keywords": [
            "Erasca",
            "Biotechnology",
            "Cancer Treatment",
            "Precision Medicine",
            "Oncology"
        ]
    },
    "faq": [
        {
            "question": "What does Erasca focus on?",
            "answer": "Erasca focuses on developing transformative therapies for cancer patients using precision medicine."
        },
        {
            "question": "Who is the CEO of Erasca?",
            "answer": "Jack D. W. W. Lee is the CEO of Erasca, Inc."
        },
        {
            "question": "Where is Erasca headquartered?",
            "answer": "Erasca is headquartered in San Diego, California, USA."
        },
        {
            "question": "What are some of Erasca's main products?",
            "answer": "Erasca's main products include ERAS-007 and ERAS-601."
        },
        {
            "question": "When was Erasca founded?",
            "answer": "Erasca was founded in 2018."
        }
    ],
    "competitors": [
        "AMGN",
        "BMY",
        "GILD",
        "MRNA"
    ],
    "related_stocks": [
        "NVDA",
        "ADBE",
        "TSLA",
        "AAPL"
    ]
}